Avricore Health Inc (V:AVCR) — Market Cap & Net Worth
Market Cap & Net Worth: Avricore Health Inc (AVCR)
Avricore Health Inc (V:AVCR) has a market capitalization of $5.48 Million (CA$7.58 Million) as of September 18, 2026. Listed on the V stock exchange, this Canada-based company holds position #28495 globally and #1260 in its home market, demonstrating a -7.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Avricore Health Inc's stock price CA$0.06 by its total outstanding shares 126369664 (126.37 Million). Also see Avricore Health Inc asset portfolio for a full breakdown of the balance sheet.
Avricore Health Inc Market Cap History: 2015 to 2026
Avricore Health Inc's market capitalization history from 2015 to 2026. Data shows change from $687.43 Million to $5.48 Million (-34.81% CAGR). Also see AVCR cash flow metrics for how efficiently the company converts equity into cash flow.
Avricore Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Avricore Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Avricore Health Inc stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
8.56x
Avricore Health Inc's market cap is 8.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $20.11 Million | $1.01 Million | -$2.61 Million | 19.84x | N/A |
| 2017 | $29.25 Million | $537.71K | -$2.74 Million | 54.40x | N/A |
| 2018 | $9.14 Million | $226.44K | -$4.14 Million | 40.37x | N/A |
| 2019 | $2.74 Million | $33.00K | -$2.11 Million | 83.10x | N/A |
| 2020 | $8.68 Million | $33.03K | -$1.17 Million | 262.92x | N/A |
| 2021 | $14.63 Million | $122.81K | -$1.71 Million | 119.10x | N/A |
| 2022 | $28.80 Million | $1.77 Million | -$818.23K | 16.28x | N/A |
| 2023 | $15.54 Million | $3.49 Million | -$701.22K | 4.46x | N/A |
| 2024 | $5.03 Million | $4.79 Million | -$668.98K | 1.05x | N/A |
| 2025 | $4.57 Million | $533.88K | -$1.86 Million | 8.56x | N/A |
Competitor Companies of AVCR by Market Capitalization
Companies near Avricore Health Inc in the global market cap rankings as of September 18, 2026. Review Avricore Health Inc tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Avricore Health Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #163 globally with a market cap of $147.17 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #472 globally with a market cap of $57.08 Billion USD ( CN¥390.06 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #577 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $648.43 |
| #163 | Danaher Corporation | NYSE:DHR | $147.17 Billion | $208.36 |
| #472 | WuXi AppTec Co Ltd | SHG:603259 | $57.08 Billion | CN¥157.71 |
| #577 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $345.34 |
Avricore Health Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Avricore Health Inc's market cap moved from $687.43 Million to $ 5.48 Million, with a yearly change of -34.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$5.48 Million | +20.00% |
| 2025 | CA$4.57 Million | -9.09% |
| 2024 | CA$5.03 Million | -67.65% |
| 2023 | CA$15.54 Million | -46.03% |
| 2022 | CA$28.80 Million | +96.88% |
| 2021 | CA$14.63 Million | +68.42% |
| 2020 | CA$8.68 Million | +216.67% |
| 2019 | CA$2.74 Million | -70.00% |
| 2018 | CA$9.14 Million | -68.75% |
| 2017 | CA$29.25 Million | +45.45% |
| 2016 | CA$20.11 Million | -97.07% |
| 2015 | CA$687.43 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Avricore Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.48 Million USD |
| MoneyControl | $5.48 Million USD |
| MarketWatch | $5.48 Million USD |
| marketcap.company | $5.48 Million USD |
| Reuters | $5.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to A… Read more